Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.17 USD -8.59% Market Closed
Market Cap: 215.4m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Nektar Therapeutics
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nektar Therapeutics
PP&E Net Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Nektar Therapeutics
NASDAQ:NKTR
PP&E Net
$24.4m
CAGR 3-Years
-49%
CAGR 5-Years
-30%
CAGR 10-Years
-10%
Johnson & Johnson
NYSE:JNJ
PP&E Net
$20.5B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
PP&E Net
$8.3B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
7%
Pfizer Inc
NYSE:PFE
PP&E Net
$19B
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
PP&E Net
$23.4B
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
PP&E Net
$16.2B
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
7%

See Also

What is Nektar Therapeutics's PP&E Net?
PP&E Net
24.4m USD

Based on the financial report for Jun 30, 2024, Nektar Therapeutics's PP&E Net amounts to 24.4m USD.

What is Nektar Therapeutics's PP&E Net growth rate?
PP&E Net CAGR 10Y
-10%

Over the last year, the PP&E Net growth was -53%. The average annual PP&E Net growth rates for Nektar Therapeutics have been -49% over the past three years , -30% over the past five years , and -10% over the past ten years .

Back to Top